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editorial
Twenty-first century: the beginning of the replacement 
parts era?
Século XXI: o início da era das peças de reposição?
Alessandro Wasum MarianiI, Paulo Manuel Pêgo-FernandesII
For many years, science fiction explored the idea of treating diseases by means of using artificial 
devices. References to replacement of human organs by implantable mechanical devices can be 
found in many books and films. The advances within medicine and bioengineering that have 
been achieved between the end of the twentieth century and the present date seem to be turn-
ing this dream into reality.
There are now six indexed scientific journals specifically focusing on this topic (Artificial 
Organs; Journal of Artificial Organs; Artificial Organs Today; Biomaterials, Artificial Cells, and 
Artificial Organs; Biomaterials, Medical Devices and Artificial Organs; and Trends in Bioma-
terials and Artificial Organs), and there is absolutely no doubt that this exemplifies the impor-
tance of this subject. Another indication of the seriousness of such research is that a search in 
the PubMed database using the key word “Artificial Organs” produces 43,411 retrieved results.
The interest in this field has grown as materials with greater biocompatibility have become 
available and as device miniaturization has progressively accelerated.1 Private initiative, sepa-
rately or in association with university departments and research institutes, has funded a good 
proportion of this research, which has already resulted in patents and commercially marketed 
devices. The need for specialized professionals, whether as physicians, engineers, biologists or 
bioengineers, is growing and thus opening up new avenues for these professions. 
Among the organs that might be replaced, research is advancing particularly in relation 
to development of an artificial heart, kidney replacement therapy using “portable” machines, 
replacement limb orthoses and devices performing the endocrine function of the pancreas. 
Dialysis is the most widely used form of replacement of internal organ function with an artificial 
device. However, the need for dialysis sessions in which the patient remains literally a prisoner of the 
machine has a major impact on the quality of life of patients with kidney failure. Miniaturization of 
dialysis systems has now made it possible to construct and, on an experimental basis, to use porta-
ble dialysis devices that can be attached to the patient’s body, thus allowing some activities to be per-
formed during the dialysis period. In 2008, Gura et al. published a paper on a non-implantable dialy-
sis device that was adapted to be inserted in a vest, thereby providing the patient with full mobility.2
Development of an artificial heart has now been studied for approximately 50 years. 
Today, this research has given rise to several long-term devices known as VADs (ventricular 
assist devices), which can be implanted. These devices enable life support through increased 
cardiac function for prolonged periods. Among these, the ones that have been most studied 
are: DeBakey VAD (MicroMed, Houston, United States), HeartMate II (Thoratec, Pleasanton, 
United States), DuraHeart (Terumo, Ann Arbor, United States), Incor (Berlin Heart, Germany) 
and HeartWare HVAD (HeartWare, Framingham, United States). 
Although complete artificial hearts now exist, the problems inherent to such devices (need 
for anticoagulation and battery life, among others) have so far meant that they are not used 
as the definitive treatment for most patients. Their use is often as a bridge to transplantation.3 
Nevertheless, since research is heading towards solutions for these problems, many investi-
gators believe that such devices will be increasingly used in a definitive manner, within a few 
years. Another important point is that studies have already demonstrated that these devices, 
even with their limitations, have the capacity to increase not only the survival but also the 
quality of life of patients with advanced heart diseases.4
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Refinement of the bioengineering will also make it possible for organs with endocrine functions to be replaced. The best examples 
are systems capable of replacing the endocrine function of the pancreas. Devices known as “insulin bombs”, which have been devel-
oped and are already in clinical use, consist of microprocessor systems that measure blood glucose levels and automatically respond 
with insulin infusions. No implantable models are currently commercially available, but the progressive reduction in volume and 
increase in precision of these devices indicate that, in the near future, an “implantable artificial endocrine pancreas” may become avail-
able for treating diabetes mellitus.5
Although ventilatory support and oxygenation machines (extracorporeal circulation) are well-known replacements for lung func-
tion, no prototypes for lungs that could be implantable yet exist. Nonetheless, the emergence of smaller-sized devices such as the New 
Lung,6 along with advances in tissue bioengineering, can be expected to motivate researchers in this field.
Medicine and engineering are rapidly and consistently advancing together within the field of development of artificial organs. 
Recent papers like those described here signal that we will soon have new therapeutic alternatives available. However, the real impact 
of these devices on longevity and quality of life among the population can be expected to remain unknown for many years. The high 
estimated cost of using these products and what this will represent for the already far too high cost of modern medicine is the most 
worrying factor.
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